Earnings

In this article

Dina Rudick | Boston Globe | Getty Images

Crocs reported second-quarter earnings that beat on the top and bottom line Thursday, raising its full-year revenue guidance amid strong global demand.

The shoemaker’s stock jumped nearly 3% in premarket trading.

Here’s how the company did compared with what analysts surveyed by Refinitiv were anticipating:

  • Earnings per share: $2.23 adjusted vs. $1.60 expected
  • Revenue: $640.8 million vs. $565.2 million expected

During the second quarter, Croc’s net income grew to $319.0 million , or $4.93 per share, compared to $56.6 million, or 83 cents per share, from a year earlier.

Excluding one-time adjustments, the company earned $2.23 a share, beating the $1.60 that analysts surveyed by Refinitiv were anticipating.

Revenues in the second quarter grew 93% to $640.8 million, from $331.5 million a year earlier. The company’s digital sales grew 25.4% to represent 36.4% of revenue, compared to 56.1% a year ago.

Crocs raised its full year guidance, and now expects its revenue to grow between 60% to 65% compared to 2020. Last quarter, the retailer raised its guidance for this year, saying it expects sales to grow 40% to 50%.

“We continue to see strong consumer demand for the Crocs brand globally. On the back of record second quarter results and continued momentum, we are raising our full year 2021 guidance,” said CEO Andrew Rees. “We are also committing to net zero emissions by 2030, enabling us to provide ‘comfort without carbon’ to our customers worldwide. I believe we can deliver sustained, highly profitable growth while having a positive impact on our planet and our communities.”

The shoemaker’s sales boomed during the pandemic as consumers sought more comfortable footwear.

The company had also said it plans to experiment with new designs that build on its clogs and release more sandals. Croc’s sandals sales were up 17% in the first quarter.

Find the full press release from Crocs here.

This is breaking news please check back for updates.

Articles You May Like

Top Wall Street analysts favor these 3 stocks for their growth potential
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Samsung Electronics’ operating profit jumps 932.8% in first quarter, beats expectations
Trump advisors are considering plans to dramatically revamp the Fed, WSJ report says
Peloton CEO Barry McCarthy to step down, company to lay off 15% of staff as it looks to refinance debt